CryoPort, Inc. (NASDAQ:CYRX – Get Free Report) insider Edward Zecchini sold 33,600 shares of the stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $14.47, for a total transaction of $486,192.00. Following the completion of the sale, the insider directly owned 109,719 shares in the company, valued at approximately $1,587,633.93. This represents a 23.44% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.
CryoPort Stock Performance
Shares of NASDAQ:CYRX traded up $0.24 during trading hours on Friday, reaching $14.62. The stock had a trading volume of 502,102 shares, compared to its average volume of 554,117. CryoPort, Inc. has a 1 year low of $6.16 and a 1 year high of $16.73. The firm’s 50 day moving average is $12.30 and its 200-day moving average is $10.30. The stock has a market capitalization of $736.85 million, a price-to-earnings ratio of 10.83 and a beta of 1.90.
CryoPort (NASDAQ:CYRX – Get Free Report) last announced its quarterly earnings data on Monday, May 4th. The company reported ($0.23) EPS for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.03). CryoPort had a net margin of 41.57% and a negative return on equity of 7.92%. The firm had revenue of $47.80 million during the quarter, compared to analysts’ expectations of $44.86 million. Analysts forecast that CryoPort, Inc. will post -0.85 EPS for the current year.
Wall Street Analyst Weigh In
Read Our Latest Stock Analysis on CryoPort
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently modified their holdings of the stock. UBS Group AG raised its stake in shares of CryoPort by 6.8% during the fourth quarter. UBS Group AG now owns 1,421,884 shares of the company’s stock worth $13,650,000 after purchasing an additional 90,363 shares during the last quarter. Mak Capital One LLC purchased a new position in CryoPort in the 3rd quarter valued at $7,756,000. First Eagle Investment Management LLC acquired a new position in CryoPort in the 4th quarter valued at $2,996,000. Legato Capital Management LLC acquired a new position in CryoPort in the 4th quarter valued at $443,000. Finally, Segall Bryant & Hamill LLC purchased a new position in CryoPort during the 3rd quarter worth $652,000. 92.90% of the stock is currently owned by hedge funds and other institutional investors.
CryoPort Company Profile
CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.
CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.
Featured Articles
- Five stocks we like better than CryoPort
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.
